PSEN1 and Alzheimer disease: PSEN1 mutations impair its protein stability and AD patients bearing the mutations showed lower levels of Aβ in the CSF (i.e., reflected more accumulation of Aβ in the brain parenchyma) than AD patients without mutations [79,80].